Improving Stone Clearance After Extracorporeal Shock Wave Lithotripsy in Urolithiasis Patients by a Special Terpene Combination (Rowatinex®): Results of a Placebo- Controlled, Randomized Trial  Imre Romics, György Siller, Ralf Kohnen, Stelios Mavrogenis, József Varga, Endre Holman  European Urology Supplements  Volume 9, Issue 12, Pages 819-825 (December 2010) DOI: 10.1016/j.eursup.2010.11.007 Copyright © 2010 Terms and Conditions

Fig. 1 Rate of patients with stone-free status within 12 wk after extracorporeal shock wave lithotripsy in the intent-to-treat and per-protocol completer set population. ITT=intent-to-treat; PP CS=per-protocol completer set. European Urology Supplements 2010 9, 819-825DOI: (10.1016/j.eursup.2010.11.007) Copyright © 2010 Terms and Conditions

Fig. 2 Survival distribution functions of the intent-to-treat population; time to stone-free status Dashed line: placebo; solid line: the terpene combination group (log-rank test; p=0.0061). European Urology Supplements 2010 9, 819-825DOI: (10.1016/j.eursup.2010.11.007) Copyright © 2010 Terms and Conditions